<DOC>
	<DOC>NCT02339246</DOC>
	<brief_summary>The purpose of the study is to compare the pharmacokinetic parameters of three different formulations of tacrolimus. Eligible patients will be treated with all three formulations in a pre-defined sequence.</brief_summary>
	<brief_title>Pharmacokinetic Comparison Of All FK-506 Formulations</brief_title>
	<detailed_description>The pharmacokinetic parameters T(max), C(max) and AUC(0-24) will be compared between the three formulations Envarsus XR once daily, Astagraf XL once daily and Prograf Twice daily.</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>1. Renal transplant recipients, males or females, of 18 years of age or above. 2. Able to participate and willing to give written informed consent and to comply with study visits and restrictions. 3. Able to understand English. 4. Patients having received a primary or secondary renal transplant 1. Evidence of acute rejection episode within the past three months prior to screening. 2. Recipients of organ transplants other than kidney. 3. Patients who are known to be HIV positive.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>